Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gaviscon Double Action Liquid versus placebo pH catheter pilot study
2011-004725-27Phase 2Completed
- Sponsor
- Reckitt
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Gaviscon Double Action in gastroesophageal reflux disease (GERD) and dyspepsia (2 arms), sponsored by Reckitt. Primary endpoint: Electrode 6 pH over time in the fasted state. Started Dec 2011; status: completed.
02
Drugs
Gaviscon Double Action
03
Conditions
gastroesophageal reflux disease (GERD)dyspepsia
Beyond the preview
Go deeper on 2011-004725-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004725-27.